Related Experiment Videos

ADAM15 is an adherens junction molecule whose surface expression can be driven by VE-cadherin

Claire Ham1, Bodo Levkau, Elaine W Raines

  • 1British Heart Foundation Laboratories, Department of Medicine, University College London, London, United Kingdom.

Experimental Cell Research
|September 24, 2002
PubMed

Insights

ADAM15 protein localizes to adherens junctions, particularly with VE-cadherin, suggesting a role in endothelial cell adhesion. VE-cadherin expression drives ADAM15 surface presence, indicating a novel junctional function.

Area of Science:

  • Cell biology
  • Molecular biology
  • Biochemistry

Background:

  • ADAM15 (a disintegrin and metalloprotease domain protein) is involved in cell adhesion and shedding.
  • Its precise localization and function in cell junctions remain unclear.

Purpose of the Study:

  • To investigate the localization of ADAM15 within adherens junctions.
  • To determine the relationship between ADAM15 and VE-cadherin in cell-cell contacts.
  • To explore the role of VE-cadherin in regulating ADAM15 surface expression.

Main Methods:

  • Immunofluorescence microscopy to visualize protein localization.
  • Co-expression studies in CHO cells using ADAM15 and VE-cadherin.
  • Analysis of ADAM15 surface expression via flow cytometry and western blotting.

Main Results:

  • ADAM15 colocalizes with vascular endothelial (VE)-cadherin at adherens junctions.
  • ADAM15 accumulation at cell contacts is preceded by VE-cadherin-mediated junction formation.
  • VE-cadherin coexpression significantly enhances ADAM15 surface expression.

Conclusions:

  • ADAM15 is a novel component of adherens junctions.
  • VE-cadherin drives the surface expression of ADAM15.
  • ADAM15 may play a significant role in endothelial cell functions mediated by adherens junctions.

Related Concept Videos